Status:
RECRUITING
Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-70 years
Brief Summary
Investigators aim to investigate whether circulating tumor DNA is a sensitive marker to evaluate patients' response to neoadjuvant chemotherapy
Detailed Description
Neoadjuvant chemotherapy(NAC) is traditionally for locally advanced disease, converting an inoperable to a resectable tumor.In recent years, it has become an option for patients of lower tumor stage t...
Eligibility Criteria
Inclusion
- Female patients undergoing NAC
- Age: 18-70 yrs
- Any menopausal status
- Any hormal receptor status
Exclusion
- Metastasis discovered during NAC
- Lost more than 2 blood samples during NAC and surgery
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03260192
Start Date
September 1 2013
End Date
December 1 2025
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunyat-sen Memorial Hospital
Guandong, Guangdong, China